Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lada Leyens

Showing results (11-20 of 25) with videos related to

Pageof 3
Sort By:
Personalized Medicine|May 17, 2018
Working towards personalization in medicine: main obstacles to reaching this vision from today's perspectiveLada Leyens, Denis Horgan, Jonathan A Lal, et al.
Retrovirology|February 6, 2009
HIV-1 exploits importin 7 to maximize nuclear import of its DNA genomeLyubov Zaitseva, Peter Cherepanov, Lada Leyens, et al.
Perspectives in Clinical Research|November 29, 2023
Collaborative clinical trials on infectious disease among the G20 nations using scientometric analysisViola Savy Dsouza, Jestina Rachel Kurian, K Cauvery, et al.
Therapeutic Innovation & Regulatory Science|September 8, 2023
Comparison of the Latin America Regulation Landscape and International Reference Health Authorities to Hasten Drug Registration and Clinical Research ApplicationsUrimara Argotti, Lada Leyens, Carlos Lisbona, et al.
Public Health Genomics|November 14, 2015
Clinical Trials, Data Protection and Patient Empowerment in the Era of the New EU RegulationsAnastassia Negrouk, Denis Horgan, Alessandra Gorini, et al.
Public Health Genomics|November 18, 2014
An index of barriers for the implementation of personalised medicine and pharmacogenomics in EuropeDenis Horgan, Marleen Jansen, Lada Leyens, et al.
Scientific Reports|April 10, 2026
Navigating the EMA qualification of novel methodologies for digital endpoints: lessons from the DEEP project proof of conceptLada Leyens, Mireille Muller, Cathelijne de Gram, et al.
Journal of Cancer Policy|December 21, 2025
INNOVATIVE ONCOLOGY TRIAL DESIGNS: TIME TO ACT A review with recommendations of the Cancer Drug Development ForumRosa Giuliani, Nafsika Kronidou-Horst, Christina Yap, et al.
Clinical and Translational Science|July 29, 2024
Assessing the net financial benefits of employing digital endpoints in clinical trialsJoseph A DiMasi, Abigail Dirks, Zachary Smith, et al.
European Journal of Cancer (Oxford, England : 1990)|October 11, 2023
Modified study designs to expand treatment options in personalised oncology: a multistakeholder viewChristophe Le Tourneau, Fabrice André, Åslaug Helland, et al.
Pageof 3

Showing results (11-20 of 25) with videos related to

Sort By:
Pageof 3
Personalized Medicine|May 17, 2018
Working towards personalization in medicine: main obstacles to reaching this vision from today's perspectiveLada Leyens, Denis Horgan, Jonathan A Lal, et al.
Retrovirology|February 6, 2009
HIV-1 exploits importin 7 to maximize nuclear import of its DNA genomeLyubov Zaitseva, Peter Cherepanov, Lada Leyens, et al.
Perspectives in Clinical Research|November 29, 2023
Collaborative clinical trials on infectious disease among the G20 nations using scientometric analysisViola Savy Dsouza, Jestina Rachel Kurian, K Cauvery, et al.
Therapeutic Innovation & Regulatory Science|September 8, 2023
Comparison of the Latin America Regulation Landscape and International Reference Health Authorities to Hasten Drug Registration and Clinical Research ApplicationsUrimara Argotti, Lada Leyens, Carlos Lisbona, et al.
Public Health Genomics|November 14, 2015
Clinical Trials, Data Protection and Patient Empowerment in the Era of the New EU RegulationsAnastassia Negrouk, Denis Horgan, Alessandra Gorini, et al.
Public Health Genomics|November 18, 2014
An index of barriers for the implementation of personalised medicine and pharmacogenomics in EuropeDenis Horgan, Marleen Jansen, Lada Leyens, et al.
Scientific Reports|April 10, 2026
Navigating the EMA qualification of novel methodologies for digital endpoints: lessons from the DEEP project proof of conceptLada Leyens, Mireille Muller, Cathelijne de Gram, et al.
Journal of Cancer Policy|December 21, 2025
INNOVATIVE ONCOLOGY TRIAL DESIGNS: TIME TO ACT A review with recommendations of the Cancer Drug Development ForumRosa Giuliani, Nafsika Kronidou-Horst, Christina Yap, et al.
Clinical and Translational Science|July 29, 2024
Assessing the net financial benefits of employing digital endpoints in clinical trialsJoseph A DiMasi, Abigail Dirks, Zachary Smith, et al.
European Journal of Cancer (Oxford, England : 1990)|October 11, 2023
Modified study designs to expand treatment options in personalised oncology: a multistakeholder viewChristophe Le Tourneau, Fabrice André, Åslaug Helland, et al.
Pageof 3